Skip to content

A Study to Understand How Sleep Quality Affects Blood Sugar Control in People with Type 2 Diabetes

Exploring the Relationship between Sleep Quality and Glycemic Control in Patients with Type 2 Diabetes Mellitus Using Actigraphy: A Prospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/07/091667
Enrollment
128
Registered
2025-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: Nil: Nil

Sponsors

Council for Scientific and Industrial research, HRDG
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Adults aged 18 years to 65 years who have been diagnosed with Type 2 diabetes mellitus with a minimum of 6 months duration. 2.Patients who are able to provide informed consent and participate in the study voluntarily. 3.Patients who have been undergoing treatment for Type 2 diabetes mellitus for at least six months. 4.Patients who are willing to undergo regular blood tests to monitor their HbA1c levels and other relevant biomarkers. 5.Patients who are willing to wear sleep monitoring devices to assess their sleep quality. 6.Patients who are able to attend regular follow up visits as part of the study protocol.

Exclusion criteria

Exclusion criteria: 1.Patients who have a history of sleep disorders other than poor sleep quality, such as sleep apnea or narcolepsy. 2.Patients who have a history of psychiatric disorders that may affect sleep quality or glycemic control, such as major depression or anxiety disorders. 3.Patients who have a history of substance abuse or dependence, including alcohol, opioids, or other drugs 4.Patients who are currently undergoing treatment with medications that may affect sleep quality or glycemic control, such as corticosteroids or beta-blockers. 5.Patients who have any significant medical conditions other than diabetes mellitus, such as cancer or chronic kidney disease, that may affect sleep quality or glycemic control. 6.Patients who are unable to comply with the study protocol or attend regular follow-up visits.

Design outcomes

Primary

MeasureTime frame
To explore the relationship between sleep quality (measured with Actigraphy) and glycemic control (measured in terms of glycated haemoglobin) in patients with type 2 diabetes mellitusTimepoint: Baseline, after 1 week and 3 months

Secondary

MeasureTime frame
To identify any factors that may confound or modify the relationship between sleep quality & glycemic control, such as age, gender, & body mass index (BMI), & body fat%Timepoint: Baseline

Countries

India

Contacts

Public ContactAyesha Juhi

All India Institute Of Medical Sciences, Deoghar

juhiayesha@gmail.com8008770156

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026